BioSpace News Archive

Biotech Bay

Dapagliflozin Reduces Progression of Kidney Disease and Renal Death in People with Type 2 Diabetes

Sub-analysis of data from DECLARE-TIMI 58 trial shows a 47% reduction of composite kidney function decline, end-stage renal disease or death, presented today at the ADA’s Scientific Sessions

June 9, 2019
·
5 min read
Lilly’s ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions

Pivotal phase 3 data in people with type 1 and type 2 diabetes presented at the American Diabetes Association’s® 79th Scientific Sessions®

June 9, 2019
·
11 min read
Biotech Bay

TrialNet Announces Type 1 Diabetes Prevention Breakthrough--

Immunotherapy delays diagnosis in people at high risk

June 9, 2019
·
4 min read
Pharm Country

A Single Course of Provention’s PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least Two Years

Results from the NIH-Sponsored “At-Risk” Study Published in The New England Journal of Medicine and Presented at the American Diabetes Association Annual Meeting

June 9, 2019
·
8 min read
Deals

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences - June 9, 2019

Five Prime Therapeutics, Inc. announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two investor conferences:

June 9, 2019
·
1 min read
Trulicity® (dulaglutide) significantly reduced major cardiovascular events for broad range of people with type 2 diabetes

REWIND data showed a consistent effect in people with and without established cardiovascular disease

June 9, 2019
·
13 min read
Hamamatsu Photonics K.K. Has Developed a Novel 3D Fluorescence Scanning Method Called “Zyncscan™“ That Performs an X-Z Plane Scan With a Light-Sheet for Cell-Based Fluorescence Assays in Microplates

Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that performs x-z plane scans using a light-sheet for cell-based fluorescence assays in microplates.

June 9, 2019
·
4 min read
Job Trends

About 3 in 100 Medicare Advantage Members Are Familiar with The Blue Button: HealthMine

Once respondents become familiar with Blue Button, 83% indicated they would consider using it

June 9, 2019
·
3 min read
Biotech Bay

Dulaglutide Reduces Cardiovascular Disease in People with Type 2 Diabetes

Presented at ADA’s Scientific Sessions, REWIND trial confirms dulaglutide reduces CVD risk regardless of CV history

June 9, 2019
·
6 min read
Biotech Bay

Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology

Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups

June 9, 2019
·
10 min read